SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-060440
Filing Date
2022-12-09
Accepted
2022-12-09 09:01:53
Documents
1
Period of Report
2022-12-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6317
  Complete submission text file 0001209191-22-060440.txt   7778
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Issuer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2100 E 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address
Link David Charles (Reporting) CIK: 0001889464 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39871 | Film No.: 221453749